Efficacy Of Onapristone In Pr-Expressing Tumors

Efficacy of Onapristone in PR-Expressing Tumors

Targeted Oncology

Safety and PK Results From an Ongoing Phase I-II Study of ONA in Patients With PR-Expressing Cancers

Targeted Oncology

PHARMACOLOGY OF Onapristone ; Overview, Mechanism of action, Pharmacokinetics, Uses, Effects

COMPASS Breast Cancer Edition: Progesterone Receptor (PR)

CancerQuest-EmoryUniversity

PALMIRA Clinical Trial: Evaluating Efficacy and Safety of Palbociclib in Advanced Breast Cancer

Treatment optimization trials in breast cancer

Updated Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Clinical Trials

Dana-Farber Cancer Institute

Preliminary data on OP-1250 + palbociclib in advanced/metastatic ER+/HER- breast cancer

What prognosis for ER Negative PR Positive and HER2 Negative Breast Cancer Survivor | Onco Power

Uncovering the role of a progesterone receptor in breast cancer migration and metastasis

AJE Video Bytes

Deciphering Mechanisms of Action of Progesterone in Breast Cancer | Oncotarget

Context Therapeutics webinar: Identification of CTIM-76, a CLDN6xCD3 bi-specific antibody

Overcoming resistance to PARPi in BRCA1-deficient breast cancer with STING agonists

Breast Cancer

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal

PeerView Oncology

Assessment of short preoperative endocrine therapy in the ADAPT and ADAPTcycle trials

Phase II Results for Abemaciclib in Pretreated HR+/HER2-Negative Breast Cancer

Targeted Oncology

Optimising patient enrolment and efficacy of precision oncology clinical trials

An Integrative Approach to Breast Cancer

Precision Analytical, Creators of the DUTCH Test

How to use endocrine therapy in premenopausal women with ER+ metastatic breast cancer

European Society for Medical Oncology (ESMO)